JPH01273597A - Production of tropan based alkaloid - Google Patents
Production of tropan based alkaloidInfo
- Publication number
- JPH01273597A JPH01273597A JP10273588A JP10273588A JPH01273597A JP H01273597 A JPH01273597 A JP H01273597A JP 10273588 A JP10273588 A JP 10273588A JP 10273588 A JP10273588 A JP 10273588A JP H01273597 A JPH01273597 A JP H01273597A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- adenosyl
- present
- tropane
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930013930 alkaloid Natural products 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 150000003797 alkaloid derivatives Chemical class 0.000 title abstract description 6
- -1 adenosyl compound Chemical class 0.000 claims abstract description 22
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 9
- 229930004668 tropane alkaloid Natural products 0.000 claims description 14
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 claims description 12
- 229930004006 tropane Natural products 0.000 claims description 12
- 150000003813 tropane derivatives Chemical class 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 8
- 125000002124 5'-adenosyl group Chemical group N1=CN=C2N(C=NC2=C1N)[C@H]1[C@H](O)[C@H](O)[C@H](O1)C* 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 abstract description 28
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 abstract description 8
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 abstract description 8
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 abstract description 8
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 abstract description 8
- 229960002646 scopolamine Drugs 0.000 abstract description 8
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 abstract description 7
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 abstract description 7
- 229930005342 hyoscyamine Natural products 0.000 abstract description 7
- 229960003210 hyoscyamine Drugs 0.000 abstract description 7
- 239000001963 growth medium Substances 0.000 abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052799 carbon Inorganic materials 0.000 abstract description 5
- 241000208296 Datura Species 0.000 abstract description 4
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 abstract description 3
- 241001469188 Duboisia Species 0.000 abstract description 3
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 abstract description 3
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 abstract description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000002609 medium Substances 0.000 description 42
- 238000000034 method Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 7
- 229960001570 ademetionine Drugs 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 210000004748 cultured cell Anatomy 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 4
- 239000003375 plant hormone Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 3
- 241001106067 Atropa Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 3
- 239000004062 cytokinin Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001465356 Atropa belladonna Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000242847 Scopolia japonica Species 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- QXYJCZRRLLQGCR-UHFFFAOYSA-N dioxomolybdenum Chemical compound O=[Mo]=O QXYJCZRRLLQGCR-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000003617 indole-3-acetic acid Substances 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- ORQVASUQSQRIMT-IDTAVKCVSA-N (2R,3S,4R,5R)-2-[2-(3-aminopropylsulfanyl)ethyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol Chemical compound NCCCSCC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12 ORQVASUQSQRIMT-IDTAVKCVSA-N 0.000 description 1
- SODPIMGUZLOIPE-UHFFFAOYSA-N (4-chlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1 SODPIMGUZLOIPE-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- LNQVTSROQXJCDD-KQYNXXCUSA-N 3'-AMP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O LNQVTSROQXJCDD-KQYNXXCUSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 240000008853 Datura stramonium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000208278 Hyoscyamus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000122904 Mucuna Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- DVYALSWUOPBGMN-IRFQHHIMSA-N N[C@@H](CC[S+](C[C@H]([C@H]([C@H]1O)O)O[C@H]1N1C2=NC=NC(N)=C2N=C1)SCC[C@@H](C(O)=O)N)C([O-])=O Chemical compound N[C@@H](CC[S+](C[C@H]([C@H]([C@H]1O)O)O[C@H]1N1C2=NC=NC(N)=C2N=C1)SCC[C@@H](C(O)=O)N)C([O-])=O DVYALSWUOPBGMN-IRFQHHIMSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000242873 Scopolia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はズボイシア、ダツラ、ハシリドコロ、ヒヨス等
のトロパン系アルカロイドを代謝産生ずる植物の組織又
は細胞を特定の培地を用いて組織培養することによりス
コポラミンおよび/又はヒヨスチアミン等のトロパン系
アルカロイドを製造する方法に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention is directed to culturing the tissues or cells of plants that metabolize tropane-based alkaloids, such as Zboisia, Datura, Hashiridokoro, Hiyosu, etc., using a specific medium. The present invention relates to a method for producing tropane alkaloids such as scopolamine and/or hyoscyamine.
(従来の技術)
スコポラミンは鎮痙剤、鎮痛剤および副交感神経しゃ断
薬として、またヒヨスチアミンは副文惑神経しゃ断薬と
して、それぞれ医薬として重用されている。これらの化
合物は、天然の植物体中から抽出して製造されているが
、天然物を原料としているため、その生産が天候に左右
されること、収穫時期が限定されていることなどが問題
となっている。そのためこれらの化合物を植物の組織培
養により生産する研究が内外で数多(行われた。(Prior Art) Scopolamine is used as an antispasmodic, analgesic, and parasympathetic nerve blocker, and hyoscyamine is used as a parasympathetic nerve blocker. These compounds are manufactured by extracting them from natural plants, but because they are made from natural materials, there are problems such as their production being affected by the weather and the harvesting period being limited. It has become. Therefore, numerous studies have been conducted both domestically and internationally to produce these compounds through plant tissue culture.
カルスによる生産では、山田らによるヒヨスのカルスに
よる生産例が知られている( Plant Ce1lR
eports上、101〜103(1982) )が、
スコポラミン含量は20ppmと、天然の植物体中の含
量と比較して低いものであった。また山田らは、ズボイ
シア(Duboisia Leichhardtii
F、 t4uell)の組織培養により得られる不定根
中に著量のスコポラミンおよびヒヨスチアミンが存在す
ることを見出している( Plant Ce1l Re
ports 3.186〜188(1984) )が、
その量はまだ充分とは言えないものであった。Regarding production by callus, there is a known example of production by Yamada et al. using henbane callus (Plant Ce1lR
eports, 101-103 (1982)),
The scopolamine content was 20 ppm, which was lower than the content in natural plants. Furthermore, Yamada et al.
We found that significant amounts of scopolamine and hyoscyamine were present in the adventitious roots obtained by tissue culture of Plant Ce1l Re.
ports 3.186-188 (1984)),
The amount was still not enough.
そこで、ズボイシア不定根の各種培養条件を検龜十し、
培地のアンモニウムイオンと硝酸イオンの比率を0.2
以上にすることおよび培地の溶存酸素濃度を10ないし
65ppmとすることにより、トロパン系アルカロイド
の生産性を向上させることを見出し、本出願人はそれぞ
れ特開昭62−6675号および特開昭62−6674
号として特許出願をしているが、工業的な見地からはそ
の生産性を更に高めることが望まれる。Therefore, we investigated various culture conditions for Zboisia adventitious roots.
The ratio of ammonium ions and nitrate ions in the medium was set to 0.2.
The present applicant has discovered that the productivity of tropane alkaloids can be improved by adjusting the concentration of dissolved oxygen in the medium to 10 to 65 ppm, and the present applicant has discovered that the productivity of tropane-based alkaloids can be improved by adjusting the concentration of dissolved oxygen in the medium to 10 to 65 ppm, and the present applicant has discovered that the productivity of tropane-based alkaloids can be improved by adjusting the concentration of dissolved oxygen in the medium to 10 to 65 ppm. 6674
Although a patent application has been filed for this technology, from an industrial standpoint, it is desirable to further increase its productivity.
したがってこのような組織培養によりトロパン系アルカ
ロイドの工業的な生産を目指す場合、さらに生産性を高
めることが重要な課題であった。Therefore, when aiming at industrial production of tropane-based alkaloids using such tissue culture, it has been an important issue to further increase productivity.
(課題を解決するための手段〕
前述のような事情にかんがみ、本発明者らは、ズボイシ
ア、ダツラ、ハシリドコロおよびヒヨス等のトロパン系
アルカロイドを産生ずる植物の不定根等のMi繊、細胞
を効率よく培養する方法を研究した結果、次のような事
実を見出した。(Means for Solving the Problems) In view of the above-mentioned circumstances, the present inventors have devised a method to efficiently collect Mi fibers and cells of adventitious roots of plants that produce tropane alkaloids, such as Zboisia, Datura, Hashiridokoro, and Hiyosu. As a result of research into culturing methods, the following facts were discovered.
すなわち該植物の組織又は細胞を、アデノシル化合物又
はサイクリックアデノシルリン酸を特定の濃度で含有す
る培地を用いて組織培養を行うと、得られる培養細胞あ
るいは不定根等の培養によって得られる培養組織中のト
ロパン系アルカロイドの含量が向上するか、あるいは培
養細胞、不定根等の培養組織の生育が促進され、結果と
してトロパン系アルカロイドの生産性が向上することを
見出し本発明を完成するに到った。That is, when tissues or cells of the plant are cultured using a medium containing an adenosyl compound or cyclic adenosyl phosphate at a specific concentration, the resulting cultured cells or cultured tissues obtained by culturing adventitious roots, etc. The present inventors have completed the present invention by discovering that the content of tropane alkaloids is increased, or the growth of cultured tissues such as cultured cells and adventitious roots is promoted, resulting in improved productivity of tropane alkaloids.
すなわち、本発明によれば、トロパン系アルカロイドを
産生ずる植物の組織又は細胞をアデノシル化合物又はサ
イクリックアデノシルリン酸を含有する培地を用いて組
織培養してトロパン系アルカロイドを生産することを特
徴とするトロパン系アルカロイドの生産方法が提供され
る。That is, according to the present invention, tropane alkaloids are produced by culturing the tissues or cells of plants that produce tropane alkaloids using a medium containing an adenosyl compound or cyclic adenosyl phosphate. A method for producing a tropane alkaloid is provided.
本発明では組織培養はトロパン系アルカロイドを産生す
る植物を用いて行われるが、該当する植物として具体的
には、ズボイシア・ミオポロイデス(Duboisia
myoporoides)、ズボイシア・ライヒハル
デ4 (Duboisia 1eichhardtii
)等のズボイシア属植物、ダツラ・タック(Datur
a tatula)+ ダツラ・アルボレア(Datu
ra arborea)、ダツラ・ストラモニウム(D
atura stramonium)等のダツラ属植物
、スコポリア・ジャポニカ(Scopolia jap
onica)等のスコポリア属植物、ヒョシアマス・ニ
ガー(llyoscyamus ntger)等のヒヨ
ス属植物およびアトローパ・ベラドンナ(Atropa
belladonna)等のアトローパ属植物などの
ナス科植物を例示することができる。In the present invention, tissue culture is carried out using plants that produce tropane-based alkaloids.
myoporoides), Duboisia 1eichhardtii
) and other plants of the genus Zboisia, Datur
a tatula) + Datu arborea
ra arborea), Datura stramonium (D
plants of the genus Datura such as Atura stramonium, Scopolia japonica (Scopolia japonica),
plants of the genus Scopolia such as llyoscyamus ntger, plants of the genus Mucuna such as llyoscyamus ntger, and plants of the genus Atropa belladonna (Atropa belladonna).
Examples include plants of the Solanaceae family, such as plants of the genus Atropa, such as Atropa (belladonna).
本発明では前記植物の組織を培養してトロパン系アルカ
ロイドを生産するに当たって、アデノシル化合物又はサ
イクリックアデノシルリン酸を含有する培地が用いられ
る。以下これについて詳述する。In the present invention, a medium containing an adenosyl compound or cyclic adenosyl phosphate is used when culturing the plant tissue to produce a tropane alkaloid. This will be explained in detail below.
本発明で使用される培地はアデノシル化合物を必須成分
として含む培地であって、該成分以外の他の成分として
無機成分および炭素源を必須成分とし、これに植物ホル
モン類、ビタミン類を添加した培地である。The medium used in the present invention is a medium containing an adenosyl compound as an essential component, and has inorganic components and a carbon source as essential components other than this component, to which plant hormones and vitamins are added. It is.
本発明に係わるアデノシル化合物は一般式(1)〔式中
、R1は11又は低級アルキル基を示し、R2はH、0
11又はリン酸基を示し、R3はOH、リン酸基又はR
’−CHCHzCHz−3−(R’はII又は−COO
Hl )
示す。]で表わされるアデノシンとその誘導体であって
具体的には、アデノシン、3′−デオキシアデノシン、
アデノシン3′−一リン酸、アデノシン5仁−リン酸、
アデノシン5′−二リン酸、アデノシン5′−三リン酸
等のアデノシルリン酸およびS−アデノシルメチオニン
、S−アデノシルホモシスティン、S−アデノシルメチ
ルチオプロピルアミン等のS−アデノシル化合物を例示
することができる。The adenosyl compound according to the present invention has the general formula (1) [wherein R1 represents 11 or a lower alkyl group, R2 represents H, 0
11 or a phosphoric acid group, R3 is OH, a phosphoric acid group, or R
'-CHCHzCHz-3-(R' is II or -COO
Hl) Shown. ] and its derivatives, specifically adenosine, 3'-deoxyadenosine,
Adenosine 3'-monophosphate, adenosine 5-monophosphate,
Examples include adenosyl phosphates such as adenosine 5'-diphosphate and adenosine 5'-triphosphate, and S-adenosyl compounds such as S-adenosylmethionine, S-adenosylhomocystine, and S-adenosylmethylthiopropylamine. I can do it.
本発明に係わるサイクリックアデノシルリン酸類は一般
式(n)
I
B
〔式中、R1は前記一般式(1)の場合と同一〕で表さ
れるサイクリックアデノシルリン酸とその誘導体であっ
て具体的にはアデノシン3’、5’−サイクリック−リ
ン酸を例示することができる。The cyclic adenosyl phosphoric acids according to the present invention are cyclic adenosyl phosphoric acids represented by the general formula (n) I B [wherein R1 is the same as in the general formula (1)] and derivatives thereof. A specific example is adenosine 3', 5'-cyclic phosphate.
本発明ではこれら化合物のうち該化合物中のカルボキシ
ル基およびリン酸基が培地を構成する後述の無機成分と
同じ金属イオンと塩を形成しても良く、本発明ではこの
塩も培地成分として使用できる。In the present invention, the carboxyl group and phosphate group in these compounds may form a salt with the same metal ion as the inorganic component described below constituting the medium, and this salt can also be used as a medium component in the present invention. .
本発明では培地に含まれる前記したアデノシル化合物の
使用割合としては通常はIQ−’mM〜10mMの範囲
であるが、該範囲の中でもIll ”mM〜6mMの範
囲が特に好ましい。培地中のアデノシル化合物の含有量
がこの範囲外にある場合には、このような培地を用いて
組織培養を行ってもトロパン系アルカロイドの生成量は
それ程向上しないので、本発明では該成分の含有量を前
記範囲にした培地を用いて組織培養を行うのが好ましい
。In the present invention, the ratio of the adenosyl compound contained in the medium is usually in the range of IQ-'mM to 10mM, but within this range, the range of Ill'mM to 6mM is particularly preferable.Adenosyl compound in the medium If the content of the component is outside this range, the amount of tropane alkaloid produced will not improve significantly even if tissue culture is performed using such a medium. It is preferable to perform tissue culture using a culture medium.
培地中にサイクリックアデノシルリン酸を用いる場合の
使用割合は通常は0.01μM〜100μ門であるが、
この中でも0.1μM〜10μ門が好ましい。When using cyclic adenosyl phosphate in the medium, the usage rate is usually 0.01 μM to 100 μM,
Among these, 0.1 μM to 10 μM is preferable.
本発明で使用される培地において、前記したアデノシル
化合物及びサイクリックアデノシルリン酸以外の他の培
地成分については、無機成分としては、窒素、リン、カ
リウム、ナトリウム、カルシウム、マグネシウム、イオ
ウ、鉄、マンガン、亜鉛、ホウ素、モリブデン、塩素、
ヨウ素、コバルト等の元素を含む無機塩を挙げることが
でき、具体的には硝酸カリウム、硝酸ナトリウム、硝酸
アンモニウム、塩化アンモニウム、塩化カリウム、塩化
カルシウム、リン酸1水素カリウム、リン酸2水素カリ
ウム、硫酸マグネシウム、塩化マグネシウム、硫酸ナト
リウム、硫酸第1鉄、硫酸第2鉄、硫酸マンガン、硫酸
銅、モリブデン酸ナトリウム、二酸化モリブデン、ヨウ
化カリウム、硫酸亜鉛、ホウ酸、塩化コバルト等の化合
物を例示できる。In the medium used in the present invention, other medium components other than the adenosyl compound and cyclic adenosyl phosphate described above include nitrogen, phosphorus, potassium, sodium, calcium, magnesium, sulfur, iron, Manganese, zinc, boron, molybdenum, chlorine,
Examples include inorganic salts containing elements such as iodine and cobalt, specifically potassium nitrate, sodium nitrate, ammonium nitrate, ammonium chloride, potassium chloride, calcium chloride, potassium monohydrogen phosphate, potassium dihydrogen phosphate, and magnesium sulfate. Examples include compounds such as magnesium chloride, sodium sulfate, ferrous sulfate, ferric sulfate, manganese sulfate, copper sulfate, sodium molybdate, molybdenum dioxide, potassium iodide, zinc sulfate, boric acid, and cobalt chloride.
該培地の炭素源としては、ショ糖等の炭水化物とその誘
導体、脂肪酸等の有機酸およびエタノール等の1級アル
コールなどを例示できる。Examples of carbon sources for the medium include carbohydrates such as sucrose and derivatives thereof, organic acids such as fatty acids, and primary alcohols such as ethanol.
該培地の植物ホルモン類としては、例えば、ナフタレン
酢酸(NAA) 、インドール酢酸(IA^)、p−ク
ロロフェノキシ酢酸、2.4〜ジクロロフエノキシ酢酸
(2,4−D) 、インドール酪酸(IB八)およびこ
れらの誘導体等のオーキシン類およびベンジルアデニン
(BA)、カイネチン、ゼアチン等のサイトカイニン類
を例示できる。本発明ではサイトカイニン類は通常は培
地に添加しないことが望ましいが、必要に応じて添加す
る場合にはサイトカイニン類は濃度が通常10−’M(
0,02mg/ j2 )以下の低濃度で使用すること
が好ましい。Examples of plant hormones in the medium include naphthaleneacetic acid (NAA), indoleacetic acid (IA^), p-chlorophenoxyacetic acid, 2.4-dichlorophenoxyacetic acid (2,4-D), and indolebutyric acid ( Examples include auxins such as IB8) and derivatives thereof, and cytokinins such as benzyladenine (BA), kinetin, and zeatin. In the present invention, it is generally preferable not to add cytokinins to the culture medium, but when added as necessary, the concentration of cytokinins is usually 10-'M (
It is preferable to use it at a low concentration of 0.02 mg/j2) or less.
該培地のビタミン類としては、ビオチン、チアミン(ビ
タミンat)、ピリドキシン(ビタミンB6)、ピリド
キサール、ピリドキサミン、パントテン酸カルシウム、
アスコルビン酸(ビタミンC)、イノシトール、ニコチ
ン酸、ニコチン酸アミドおよびリボフラビン(ビタミン
BX)などを例示できる。The vitamins in the medium include biotin, thiamine (vitamin AT), pyridoxine (vitamin B6), pyridoxal, pyridoxamine, calcium pantothenate,
Examples include ascorbic acid (vitamin C), inositol, nicotinic acid, nicotinamide, and riboflavin (vitamin BX).
該培地のアミノ酸類としては、例えばグリシン、アラニ
ン、グルタミン酸、フェニルアラニンおよびリジンなど
を例示できる。Examples of amino acids in the medium include glycine, alanine, glutamic acid, phenylalanine, and lysine.
本発明の前記培地は、通常は、前記無機成分を約0.1
μパないし約100mM 、前記炭素源を約1g/ff
iないし約100g//!、前記植物ホルモン類を約0
、O1μnないし約100μN、前記ビタミン類を約0
.1 mg/ eないし約150mg/ I;!および
前記アミノ酸類を0ないし約100mg/、i2含ませ
て使用されることが望ましい。The medium of the present invention usually contains about 0.1 of the inorganic components.
μP to about 100mM, and about 1g/ff of the carbon source
i or about 100g//! , about 0 of the plant hormones
, O1 μn to about 100 μN, and the vitamins are about 0
.. 1 mg/e to about 150 mg/I;! It is desirable that the amino acids be used in an amount of 0 to about 100 mg/i2.
本発明のズボイシア属植物の組繊培養に用いられる前記
培地として具体的には、従来から知られている植物の組
織培養に用いられている培地、例えば、ムラシゲ・スク
ーグ(’62) (Murashige &Skoo
g )の培地、リンスマイヤー・スクーグ(R1’l−
1965) (Linsmaier & Skoog
)の培地、ホワイト(’63) (Whitelの培
地、ガンボルグ[Gamborg ]のB−5培地、三
井のM−9培地、二・ソチ・ニッチ(Nitsch N
1tsch )の培地等に前記した炭素源および植物ホ
ルモンを添加し、更に必要に応じて前記したビタミン類
、アミノ酸等を添加して調製される培地を例示できるが
、本発明ではこの中でも特にニッチ・エッチ、リンスマ
イヤー・スクーグ又はムラシゲ・スクーグの培地を用い
て調製される培地が好ましい。なお、上記した従来公知
の培地の組成に関しては、例えば、性向、中隔、古谷著
の「新植物組織培養J P386〜P391、朝食書店
、1979年に記載されている。Specifically, the medium used for the tissue culture of plants belonging to the genus Zboisia of the present invention includes a conventionally known medium used for tissue culture of plants, such as Murashige & Skoo ('62).
g) medium, Linsmeyer-Skoog (R1'l-
1965) (Linsmaier & Skoog
) medium, White ('63) (White medium, Gamborg B-5 medium, Mitsui M-9 medium, Nitsch N
An example is a medium prepared by adding the above-mentioned carbon source and plant hormone to a medium of 1tsch), and further adding the above-mentioned vitamins, amino acids, etc. as necessary. Preferably, the medium is prepared using Hetch, Linsmeyer-Skoog or Murashige-Skoog medium. The composition of the above-mentioned conventionally known culture medium is described, for example, in "New Plant Tissue Culture JP 386-P391," written by Tenshi, Septum, and Furuya, Shokusho Shoten, 1979.
本発明で使用できる前記培地は液体培地又は寒天やゼラ
チン等を通常0.5〜1%含有させた固型培地であるが
本発明では液体培地を用いることが好ましい。The medium that can be used in the present invention is a liquid medium or a solid medium containing usually 0.5 to 1% of agar, gelatin, etc., but it is preferable to use a liquid medium in the present invention.
本発明の組織培養に用いられる前記植物の組織又は細胞
として具体的には、該植物の根、葉、茎、種子、花芽な
どの植物組織片又は細胞の他、本発明に係わる組織培養
あるいは他の従来の組織培養方法によって得られる該植
物の培養細胞ないし培養組織を例示できる。本発明では
、これらの中では植物組織を前もって組織培養して得ら
れる不定根を使用して、これを本発明に係わる培地を用
いて組織培養することが特に好ましく、この場合には原
料の不定根が本発明の培地を用いて増殖培養されてトロ
パン系アルカロイドを多量含有する不定根が得られる。Specifically, the tissue or cells of the plant used in the tissue culture of the present invention include plant tissue pieces or cells such as roots, leaves, stems, seeds, flower buds, etc. of the plant, as well as tissue culture or other cells related to the present invention. Examples include cultured cells or tissue of the plant obtained by the conventional tissue culture method. In the present invention, it is particularly preferable to use adventitious roots obtained by culturing plant tissues in advance and tissue culture them using the medium according to the present invention. Adventitious roots containing a large amount of tropane alkaloids can be obtained by propagation and culture using the medium of the present invention.
また、本発明では前記した組織片あるいは細胞からカル
スを誘導し、該カルスを継代培養して得られる培養細胞
ないしは培養組織を本発明の前記培地を用いて増殖培養
してトロパン系アルカロイドを多量含有する培養物、特
に不定根を得るという組織培養の方法を用いることも好
ましい。In addition, in the present invention, callus is induced from the tissue pieces or cells described above, and the cultured cells or tissue obtained by subculturing the callus are grown and cultured using the medium of the present invention to produce a large amount of tropane-based alkaloids. It is also preferred to use methods of tissue culture to obtain cultures containing, in particular adventitious roots.
本発明では不定根を用いる場合に、植物の組織片を例え
ば毛根病菌(例えば八grobac ter i um
rh izogenes)で感染させ、これによって出
現する毛根を用いることもできる(例えば本出願人に係
わる特開昭62−248429号で提案した方法を用い
ることもできる。)
本発明の方法によって得られるトロパン系アルカロイド
・とじて具体的には、スコポラミン、ヒヨスチアミン及
びこれらの化合物のアセチル化合物を例示できるが、こ
の中ではスコポラミンとヒヨスチアミンが好ましい。In the present invention, when using adventitious roots, plant tissue pieces are infected with hairy root disease fungi (e.g., eight grobacterium um).
tropane obtained by the method of the present invention. Specific examples of the alkaloids include scopolamine, hyoscyamine, and acetyl compounds of these compounds, and among these, scopolamine and hyoscyamine are preferred.
本発明ではトロパン系アルカロイドを含有する培養細胞
又は培養組織から該アルカロイドを分離する方法として
は、例えば薬局法等に記載されている、トロパン系アル
カロイドを含有する植物からこれら化合物を単離精製す
る場合に用いられてきた通常の方法を採用することがで
きる。In the present invention, methods for separating tropane-based alkaloids from cultured cells or cultured tissues include, for example, the method of isolating and purifying these compounds from plants containing tropane-based alkaloids, as described in the Pharmacopoeia Act, etc. Any conventional method that has been used can be used.
[実施例]
以下、本発明の方法を実施例によって更に具体的に説明
する。[Example] Hereinafter, the method of the present invention will be explained in more detail with reference to Examples.
実施例1,2,3.4及び5
当社薬草園にて栽培したDuboisia mypor
oiclesR,Brの葉を洗浄し、10%アンチホル
ミン液に10分間浸漬し、次いで滅菌水で3回洗浄した
後、約1(mに切断し、ナフタレン酢酸およびベンジル
アデニンをそれぞれ10−’Mおよび10−6Mとなる
ように添加したリンスマイヤー・スクーグの寒天培地に
置床し、25°Cで30日間培養する。カルス形成と同
時に発生した不定根を切り出し、インドール酪酸を10
−”Mになるように添加したエッチ・ニッチの液体培地
に移植し、2年間継代培養した。このようにして得た不
定根10■(乾燥重量)をインドール醋酸を10−’H
になるように添加したエッチ・エッチの液体培地2kを
含む100n+Z容の三角フラスコに移植して培養開始
後7日目にS−アデノシルメチオニン濃度が各々0.0
3mM、0.1mM、0.3n+M、1、0 mM及び
5.0mMとなるようにS−アデノシルメチオニンを先
の液体培地に添加して、さらに14日間振とう培養した
。得られた不定根を乾燥後、塩基性のクロロホルム−メ
タノール液50m!で抽出した。これに40m1のIN
硫酸を加えてアルカロイド層を硫酸層に移した。さらに
、アンモニア水2dおよびクロロホルム40m/を加え
てアルカロイドをクロロホルム層に移し、これを減圧濃
縮し、ガスクロマトグラフでアルカロイド量を分析した
。この場合のアルカロイドの生産量を表1に示した。Examples 1, 2, 3.4 and 5 Duboisia mypor grown in our herb garden
oiclesR,Br leaves were washed, immersed in 10% antiformin solution for 10 min, then washed three times with sterile water, then cut into approximately 1 (m) and treated with naphthaleneacetic acid and benzyladenine at 10-'M and Place on Linsmeyer-Skoog agar medium supplemented with 10-6M and culture at 25°C for 30 days.Adventitious roots that have developed at the same time as callus are excised, and indolebutyric acid is added at 10-6M.
-''M, and subcultured for 2 years. 10cm (dry weight) of the adventitious roots thus obtained were treated with indole acetic acid for 10cm.
The S-adenosylmethionine concentration was 0.0 on the 7th day after the culture was started.
S-adenosylmethionine was added to the liquid medium at concentrations of 3mM, 0.1mM, 0.3n+M, 1,0mM, and 5.0mM, and cultured with shaking for an additional 14 days. After drying the obtained adventitious roots, 50ml of basic chloroform-methanol solution was added. Extracted with. This has 40m1 of IN.
Sulfuric acid was added to transfer the alkaloid layer to the sulfuric acid layer. Further, 2 d of aqueous ammonia and 40 m/ml of chloroform were added to transfer the alkaloids to the chloroform layer, which was concentrated under reduced pressure and the amount of alkaloids was analyzed using a gas chromatograph. Table 1 shows the production amount of alkaloid in this case.
なお、ガスクロマトグラフの分析は以下の条件で行った
。Note that the gas chromatograph analysis was conducted under the following conditions.
カラム: 5ilicone 0V−17(1%) o
nChromosorb H(Mesh 80〜100
)3胴φX1mガラス力ラム
キャリャガス二N2
カラム温度 :200°C
比較例1
実施例1においてS−アデノシルメチオニンを添加しな
い培地を用いた以外は該実施例と同様に行った結果を表
1に示した。Column: 5ilicone 0V-17 (1%) o
nChromosorb H (Mesh 80-100
) 3 cylinders φ x 1m glass force ram carrier gas 2N2 Column temperature: 200°C Comparative Example 1 The same procedure as in Example 1 was used except that a medium without S-adenosylmethionine was used. The results are shown in Table 1. Ta.
実施例6.7
実施例1でS−アデノシルメチオニンの代りにアデノシ
ン5′−−リン酸を0.11及び1.0mM用いた以外
は該実施例と同様に行った結果を表1に示した。Example 6.7 The same procedure as in Example 1 was performed except that 0.11 and 1.0 mM of adenosine 5'--phosphate was used instead of S-adenosylmethionine. The results are shown in Table 1. Ta.
比較例2
実施例1でS−アデノシルメチオニンの代りにアデノシ
ン5′−一リン酸を10.0mM用いた以外は該実施例
と同様に行った結果を表1に示した。Comparative Example 2 Table 1 shows the results of the same procedure as in Example 1 except that 10.0 mM of adenosine 5'-monophosphate was used instead of S-adenosylmethionine.
実施例8,9.10
実施例1でS−アデノシルメチオニンの代りにアデノシ
ン3’、5’−サイクリック−リン酸を0.1μM、1
.0μ門及び10.0μ門用いた以外は該実施例と同様
に行った結果を表1に示した。Examples 8, 9.10 In Example 1, adenosine 3', 5'-cyclic phosphate was added at 0.1 μM and 1 in place of S-adenosylmethionine.
.. Table 1 shows the results obtained in the same manner as in the example except that 0 μm gate and 10.0 μm gate were used.
(本頁以下余白)
〔発明の効果]
本発明の組織培養によるトロパン系アルカロイドの生産
方法を採用すれば、従来法に比べてトロパン系アルカロ
イドを、中でも特にスコポラミンおよび/又はヒヨスチ
アミンを大量に効率よく生産することができる。(Margins below this page) [Effects of the invention] If the method for producing tropane alkaloids by tissue culture of the present invention is adopted, tropane alkaloids, especially scopolamine and/or hyoscyamine, can be produced in large quantities more efficiently than in conventional methods. Can be produced well.
出願人 生体機能利用化学品新製造技術研究組合代理人
弁理士 平 木 祐 輔
代理人 弁理士 石 井 貞 次Applicant: New Manufacturing Technology Research Association for Chemicals Utilizing Biofunctions Agent: Yusuke Hiragi, Attorney: Sadatsugu Ishii
Claims (3)
は細胞をアデノシル化合物又はサイクリックアデノシル
リン酸を含有する培地を用いて組織培養してトロパン系
アルカロイドを生産することを特徴とするトロパン系ア
ルカロイドの生産方法。(1) Tropane-based alkaloids are produced by culturing the tissues or cells of plants that produce tropane-based alkaloids using a medium containing an adenosyl compound or cyclic adenosyl phosphate. Production method.
M含有する培地を用いることを特徴とする請求項1記載
のトロパン系アルカロイドの生産方法。(2) Adenosyl compound at 10^-^2mM to 6mM
The method for producing tropane alkaloids according to claim 1, characterized in that a medium containing M is used.
し10μn含有する培地を用いることを特徴とする請求
項1記載のトロパン系アルカロイドの生産方法。(3) The method for producing tropane-based alkaloids according to claim 1, characterized in that a medium containing 0.1 μM to 10 μn of cyclic adenosyl phosphate is used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10273588A JPH01273597A (en) | 1988-04-27 | 1988-04-27 | Production of tropan based alkaloid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10273588A JPH01273597A (en) | 1988-04-27 | 1988-04-27 | Production of tropan based alkaloid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01273597A true JPH01273597A (en) | 1989-11-01 |
Family
ID=14335501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10273588A Pending JPH01273597A (en) | 1988-04-27 | 1988-04-27 | Production of tropan based alkaloid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01273597A (en) |
-
1988
- 1988-04-27 JP JP10273588A patent/JPH01273597A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05219974A (en) | Production of tropane alkaloid | |
JPH01273597A (en) | Production of tropan based alkaloid | |
JPH01124383A (en) | Tissue culture of plant | |
JPH0220291A (en) | Production of tropane-type alkaloid | |
JPH01240194A (en) | Production of tropane-based alkaloid | |
JPH02117393A (en) | Production of tropane alkaloid | |
JPH01243995A (en) | Production of tropane based alkaloid | |
JPH02303430A (en) | Method for carrying out tissue culture of adventive root of tropane-based alkaloid producing plant | |
JPS63167793A (en) | Production of tropane based alkaloid | |
JPH01218595A (en) | Production of tropan-based alkaloid | |
JPH02303431A (en) | Production of tropane-based alkaloid | |
JP2502308B2 (en) | Method for culturing protoplasts of herbaceous plant | |
JPS6387991A (en) | Production of tropane-type alkaloid | |
JPS6339595A (en) | Production of alkaloid | |
JPS6384497A (en) | Production of tropan based alkaloid | |
JPS626675A (en) | Method of tissue culture for duboisia leichhardtu f. muell | |
JPH01300890A (en) | Cell capable of highly producing tropane-based alkaloid and production of said cell | |
JPS619227A (en) | Tissue culture of buttercup plant | |
JPS63129989A (en) | Production of tropane alkaloid | |
JPH07184679A (en) | Production of anthocyanin-based pigment and medium to be used for the production | |
JPS63167790A (en) | Tissure culture | |
JPS63116691A (en) | Tissue cultivation method for plant | |
JPH01165391A (en) | Production of berberine type alkaloid | |
JPH0648991B2 (en) | Method for producing tropane alkaloid | |
JPH02107194A (en) | Production of triterpenoid |